$$
K 1 4 1 1 1 4
$$

# JUL 2 5 2014

# 510(k) SUMMARY

SUBMITTED BY:

Mari Meyer   
Director, Regulatory Affairs   
DiaSorin Inc.   
1951 Northwestern Avenue   
P.O. Box 285   
Stillwater, MN 55082-0285   
Phone (651) 439-9710   
Fax (651) 351-5669   
Email: mari.meyer@diasorin.com

NAME OF DEVICE:

Trade Name:

LIASON® Anti-HAV, LIAISO®XLAnalyzer

Common Names/Descriptions:

Hepatitis Anti-HAV, serological assay, Automated Chemiluminescent Immunoassay Analyzer

Regulation Number:

21 CFR 866.3310

Regulation Name:

Hepatitis A virus (HAV) serological assays

Regulation Class:

Class II

Product Codes:

LOL, JJF

PREDICATE DEVICES:

LIAISON® XL Analyzer Reference K103529

# DEVICE DESCRIPTION:

# INTENDED USE:

The LIAISON® Anti-HAV assay is an in vitro chemiluminescent immunoassay intended for the qualitative detection of total antibodies to hepatitis A (anti-HAV) in human serum and sodium heparin plasma samples using the LIAISON® Analyzer family. The assay is indicated as an aid in the laboratory diagnosis of current or previous HAV infections in conjunction with other serological and clinical information and to determine the presence of an antibody response to HAV in vaccine recipients.

This assay is not intended for screening blood or solid or soft tissue donors. Assay performance characteristics have not been established for immunocompromised or immunosuppressed patients. The user is responsible for establishing assay performance characteristics in these populations. Caution: U.S. Federal Law restricts this device to sale by or on the order of a physician.

Section 5

The LIAlSON XL Analyzer is an automated discrete continuous loading chemiluminescent immunoassay (CLIA) analyzer for in vitro diagnostic analysis of CLIAs on human specimens cleared for use on the analyzer. It is only to be used with FDA cleared chemiluminescent immunoassays that are marketed by DiaSorin for the LIAISON XL Analyzer. The analyzer can be connected to a third party Laboratory Automation System (LAS) which has been previously cleared for use with FDA cleared assays.

The LIAISON® Control Anti-HAV (negative and positive) is intended for use as assayec quality control samples to monitor the performance of the LIAISON® Anti-HAV assay.

The performance characteristics of LIAlSON® controls have not been established for any other assays or instrument platforms different from LIAISON®, LIAISON® XL and LIAISON® XL with LIAISON® XL Workcell Upgrade Kit.

# DESCRIPTION:

The LIAlSON® XL Analyzer is an in vitro diagnostic device consisting of loading areas (for samples, Reagent Integrals, ancillary reagents, Starter Reagents, Cuvettes, Disposable Tips, water, Wash Buffer, maintenance liquid); incubator, wash station, reader, and a barcode reader for reagents and samples. Installation of the LIAlSON® XL Workcell Upgrade Kit allows the LIAISON® XL Analyzer to be used with a compatible LAs and extends the sample pipetting capabilities to a point-in-space located external to the analyzer.

# COMPARISON TO PREDICATE DEVICE:

The following table compares the LIAISON® XL Analyzer to the LIAISON® XL Workcell Upgrade Kit.

Summary of Device Similarities and Differences:   

<table><tr><td colspan="1" rowspan="1">Summar</td><td></td><td></td></tr><tr><td colspan="1" rowspan="1">Characteristic</td><td colspan="1" rowspan="1">Predicate DeviceLIAISON® XL analyzer</td><td colspan="1" rowspan="1">New Device: LIAisON® XL with LIAiSON®XL Workcell Upgrade Kit</td></tr><tr><td colspan="1" rowspan="1">FDA k#</td><td colspan="1" rowspan="1">K103529</td><td colspan="1" rowspan="1">K141116</td></tr><tr><td colspan="1" rowspan="1">Intended Use</td><td colspan="1" rowspan="1">The LIAISON® Anti-HAV assay is an in vitrochemiluminescent immunoassay intended for thequalitative detection of total antibodies tohepatitis A (anti-HAV) in human serum andsodium heparin plasma samples using theLIAISON® Analyzer family. The assay isindicated as an aid in the laboratory diagnosis ofcurrent or previous HAV infections inconjunction with other serological and clinicalinformation and to determine the presence of anantibody response to HAV in vaccine recipients.This assay is not intended for screening blood orsolid or soft tissue donors. Assay performancecharacteristics have not been established forimmunocompromised or immunosuppressedpatients. The user is responsible for establishingassay performance characteristics in thesepopulations. Caution: U.S. Federal Law restrictsthis device to sale by or on the order of aphysician.The LIAISON® XL Analyzer is an automateddiscrete continuous loading chemiluminescentimmunoassay (CLIA) analyzer for in vilrodiagnostic analysis of Cl.lAs on human serum orplasma. The system menu includes infectiousdisease, bone and mineral, and endocrinologyCLlAs. It is to be used only with FDA clearedchemiluminescence immunoassays that aremarketed by DiaSorin for the LIAISON® XLAnalyzer.The LIAISON® Control Anti-HAV (negativeand positive) is intended for use as assayedquality control samples to monitor theperformance of thc LlAISON® Anti-HAV assay.The performance characteristics of LIAISON®controls have not been established for any otherassays or instrument platformns different fromLIAISON® and LIAISON XL.</td><td colspan="1" rowspan="1">The LIAISON® Anti-HAV assay is an in vitrochemiluminescent immunoassay intended forthe qualitative detection of total antibodies tohepatitis A (anti-HAV) in human serum andsodium heparin plasma samples using theLIAISON® Analyzer family. The assay isindicated as an aid in the laboratory diagnosisof current or previous HAV infections inconjunction with other serological and clinicalinformation and to determine the presence of anantibody response to HAV in vaccinerecipients.This assay is not intended for screening bloodor solid or soft tissue donors. Assayperformance characteristics have not beenestablished for immunocompromised orimmunosuppressed patients. The user isresponsible for establishing assay performancecharacteristics in these populations. Caution:U.S. Federal Law restricts this device to sale byor on the order of a physician.The LIAISON XL Analyzer is an automateddiscrete continuous loading chemiluminescentimmunoassay (CLIA) analyzer for in vitrodiagnostic analysis of CLIAs on humanspecimens cleared for use on the analyzer. It isonly to be used with FDA clearedchemiluminescent immunoassays that aremarketed by DiaSorin for the LIAISON XLAnalyzer. The analyzer can be connected to athird party Laboratory Automation System(LAS) which has been previously cleared foruse with FDA cleared assays.The LIAISON® Control Anti-HAV (negativeand positive) is intended for use as assayedquality control sanples to monitor theperformance of the LlAISON® Anti-HAVassay.The performance characteristics of LIAISON®controls have not been established for any otherassays or instrument platforms different fromLIAISON®, LIAISON® XL and LIAISON® XLwith LIAISON® XL Workcell Upgrade Kit.</td></tr><tr><td colspan="1" rowspan="1">Principles ofOperation</td><td colspan="1" rowspan="1">Chemiluminescence using magnetic particlesolid phase and chemiluminescent tracer</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Characteristic</td><td colspan="1" rowspan="1">Predicate DeviceLIAISON® XL analyzer</td><td colspan="1" rowspan="1">New Device: LIAiSON® XL with LiAISON®XL Workcell Upgrade Kit</td></tr><tr><td colspan="1" rowspan="1">FDA k#</td><td colspan="1" rowspan="1">K103529</td><td colspan="1" rowspan="1">K141116</td></tr><tr><td colspan="1" rowspan="4">Optical System</td><td colspan="1" rowspan="1">High-sensitive, low-noise photomultipliertube (PMT) operating as an ultra-fastphoton counter. Pulses are amplified by arapid electronic amplifier.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Circuit that suppresses PMT signal noise.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Linear measuring range: 300 - 650 nm</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Light peak of chemiluminescence emitted at450 nm</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">TemperatureControl</td><td colspan="1" rowspan="1">Reaction Temperature: 36°C ± 1°CReagent Storage Temperature: 11-15°C</td><td colspan="1" rowspan="1">SameSame</td></tr><tr><td colspan="1" rowspan="1">DispenseSystem</td><td colspan="1" rowspan="1">Automated pipetting of samples andreagents;Left pipetting unit used for samples(using disposable tip):Right pipetting unit used for reagents(metal needle);</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="2"></td><td colspan="1" rowspan="1">Precision syringes (sample and reagent)</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Sample Probe (disposable tip):Liquid Level Detection and ClotDetection feature (pressure)Disposable tips: 6 trays of 96 tips eachcan be loaded on board.Monitored through software counter andpresence sensor upon tip pick-up.Re-loading allowed during run</td><td colspan="1" rowspan="1">Same</td></tr></table>

<table><tr><td colspan="1" rowspan="1">Characteristic</td><td colspan="1" rowspan="1">Predicate DeviceLIAISON® XL analyzer</td><td colspan="1" rowspan="1">New Device: LIAisOn® XL withLIAISON® xL Workcell Upgrade Kit</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Reagent Probe:Liquid Level Detection (capacitive), withsoftware tracking of reagent levelOptical Liquid Verification (real-timemonitoring of liquid flow inside theprobe)</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="3">Sample Handling</td><td colspan="1" rowspan="1">Capacity:• Holds 10 sample racks,•−12 places per rack</td><td colspan="1" rowspan="1">Same (in the stand alone mode)</td></tr><tr><td colspan="1" rowspan="1">Tube types:primary tubealiquot tubepediatric</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Sample presence, sample type (calibrator,control, patient), tube size, and processingcompletion tracked by operating softwareand sample bar-code</td><td colspan="1" rowspan="1">Same (in the stand alone mode)</td></tr><tr><td colspan="1" rowspan="1">Test Orders</td><td colspan="1" rowspan="1">From LIS or middleware to analyzer</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Test Results</td><td colspan="1" rowspan="1">To LIS or middleware from analyzer</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="2">Reagent Handling</td><td colspan="1" rowspan="1">Capacity: 25 Reagent Integrals (RI), plus 4positions for Ancillary Reagents</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">RI contains all reagents required for anygiven assay (up to 7 vials per RI, first vialalways contains magnetic particles).</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Assay-specific processing and analysisparameters, calibration, lot number,expiration date, and usage (number oftests run) are controlled by operatingsoftware as communicated by RF-Tag</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="2">AdditionalReagents</td><td colspan="1" rowspan="1">• Control Set (2-3 levels)LIAISON Light Check (diagnostic toolonlyLIAISON Starter Kit (Starter Reagents 1and 2)LIAISON Wash/System Liquid (used asa wash liquid only - immunometric washstep)Purified water is also required as SystemLiquid, as fluidic filler and to perform:0reagent needle cleaning0washer needle cleaningA cleaning tank is available to host acleaning liquid suitable for automatedmaintenance purpose</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Level sensing by capacitive rod</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="5">Starter Reagents</td><td colspan="1" rowspan="1">Recognition of Starter Reagents via RF-Tag</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Two bottles of each Starter Reagent can beloaded on board</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Injection of Starter Reagents through highprecision/accuracy pump (fixed dispensingvolume)</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Dispense monitoring through optical sensor</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Injection of Starter Reagents occurs atcontrolled temperature (33-37°C)</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Characteristic</td><td colspan="1" rowspan="1">Predicate DeviceLIAISON® XL analyzer</td><td colspan="1" rowspan="1">LIAISON® xL Workcell Upgrade Kit</td></tr><tr><td colspan="1" rowspan="5">Reaction Modules</td><td colspan="1" rowspan="1">Single-cavity Cuvettes</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Storage capacity: &gt;600 Cuvettes</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Inventory monitoring through softwarecounter.Sensors detect actual presence of Cuvettes</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Reloading allowed during run</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Unloading automatic into waste bag</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="3">Test Processing</td><td colspan="1" rowspan="1">Random Access and Batch</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Continuous operation</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Sample scheduling optimized throughputprocess</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Assay Protocols</td><td colspan="1" rowspan="1">1-Step assays: 1 incubation sequence / 1wash sequence; average incubation time =10 minutes</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="2"></td><td colspan="1" rowspan="1">2-Step assays: 2 incubation sequence / 1 or2 wash sequence(s); average incubationtime = 10 minutes</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Two-point calibration of assays</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="7">Human Interface</td><td colspan="1" rowspan="1">Computer</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Touch-screen On Screen Keyboard(keyboard and mouse not supplied)</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Monitor - touch screen, color</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Printer</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Stationary barcode scanner for identificationof samples</td><td colspan="1" rowspan="1">Same(in the stand alone mode)</td></tr><tr><td colspan="1" rowspan="1">Stationary RF-Tag reader for identificationof reagents (Reagent Integrals and StarterReagents</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Handheld barcode scanner for identificationof controls</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="3">Data Analysis</td><td colspan="1" rowspan="1">Automated data reduction</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Assay-specific Master Curve with 2-pointrecalibration</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Assay-specific data reduction</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="4">QC Software</td><td colspan="1" rowspan="1">Stored lot-specific control results</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Lot-specific Levey-Jennings plotting</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Trend identification</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Statistical analyses</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="2">Specimens</td><td colspan="1" rowspan="1">Serum or plasma</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Sampling from primary, aliquot, or pediatrictubes</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="7">Disposables</td><td colspan="1" rowspan="1">Reagent Integrals</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Light Check (diagnostic tool)</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Starter Kit</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Wash/System Liquid</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Cuvettes</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Disposable Tips</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Waste Bag</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Software</td><td colspan="1" rowspan="1">Based on: Windows VistaSoftware controlling the analyzer withGraphical User Interface (v4.0.0.4 sp3)LAS interface disabled</td><td colspan="1" rowspan="1">• Same• SameLAS interface enabled</td></tr></table>

DiaSorin LIAISON® XL Workcell Upgrade Kit   

<table><tr><td colspan="2">Predicate Device</td><td rowspan="2">LIAISON® XL Workcell Upgrade Kit</td></tr><tr><td>Characteristic General Operation</td><td>LIAISON® XL analyzer The Cuvette sorting mechanism feeds the incubator, in order to have all vacant</td></tr><tr><td>General Operation</td><td>incubator positions (i.e. 80 incubation slots) always full of Cuvettes available for new pipetting tasks. Pipetting of sample and reagents occurs within the incubator. Incubator rotates (CW/CCW) in order to bring the appropriate Cuvette to one of the 3 dedicated pipetting positions. At the end of the incubation time, the incubator- washer pusher transports the Cuvette from its position in the incubator into the washer. The washer transport mechanism (spindle) moves the Cuvettes present in the washer channel one cavity position at a time, using half of the analyzer time cycle, from one washing station to the next. Each of the 6 washer needles accesses a Cavity only once. Upon completion of the wash step, the following two situations may apply:</td><td>Same Same</td></tr></table>

Table 2: Differences   

<table><tr><td rowspan=1 colspan=1>Characteristic</td><td rowspan=1 colspan=1>Predicate: LIASON XL AnalyzerK103529LIAISON® XL</td><td rowspan=1 colspan=1>New Device: LIAsON XL with LiAsON XLWorkcell Upgrade KitK141116</td></tr><tr><td rowspan=1 colspan=1>Sample Aspiration</td><td rowspan=1 colspan=1>Directly from sample tube in thesample bay of the analyzer</td><td rowspan=1 colspan=1>•  Directly from sample tube in thesample bay of the analyzer (in thestand alone mode) andDirectly from sample tube presentedby the Workcell to the aspiration point-in-space position at the analyzerinterface (in LAS mode)</td></tr><tr><td rowspan=1 colspan=1>Sample Identificationfrom bar-coded tubes</td><td rowspan=1 colspan=1>Bar-coded sample tubes (monodimension barcode) read directly byanalyzer bar code reader</td><td rowspan=1 colspan=1>Bar-coded sample tubes (monodimension barcode) read directly byanalyzer bar code reader (stand-alone mode) andBar-coded sample tubes (monodimension barcode) read by Workcellbarcode scanner.</td></tr><tr><td rowspan=1 colspan=1>LAS Communication</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>LIAISON® XL software communicates withWorkcell via LAS interface communicationprotocol</td></tr></table>

# CONCLUSION:

The results from the non-clinical studies submitted in this premarket notification demonstrate that the LIAISON® XL Workcell Upgrade Kit is substantially equivalent to the predicate device.

July 25, 2014

DIASORIN, INC.   
MARI MEYER   
DIRECTOR, REGULATORY AFFAIRS 1951 NORTHWESTERN AVE.   
P.O. BOX 285   
STILLWATER MN 55082-0285

Re: K141116 Trade/Device Name: LlAiSON XL Analyzer with LiAISON XL Workcell Upgrade Kit Regulation Number: 21 CFR 866.3310 Regulation Name: Hepatitis A virus (HAV) serological assays Regulatory Class: I1 Product Code: LOL, JJF Dated: April 29, 2014 Received: April 30, 2014

Dear Ms. Meyer:

We have reviewed your Section $\$ 10(1$ premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class 11 (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with al the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000- 1050.

If you desire spccific advice for your device on our labeling regulations (21 CFR Parts 801 and 809). please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address   
http://wvw.fda.gov/MedicalDevices/ResourccsforYou/Industry/default.htm. Also. please note the regulation entitled. "Misbranding by reference to premarket notification" (21 CFR Par 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to   
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/lndustry/default.htm.

Sincerely yours.

Stephen J. Lovell -S for

Sally Hojvat. M.Se.. Ph.D.   
Director   
Division of Microbiology Devices   
Office of In Vitro Diagnostics   
and Radiological Health   
Center for Devices and Radiological Health

Enclosure

# Indications for Use (Describe)

T LAISONntiHAVssy s  nvi eluecetmassytenr he ualitativee t antioies hepati anti-HA)inhuman eum nsodiuepar plasm samplesusing theIAIS H in vaccine recipients.

h b tablises e s abih of a physician.

The LIAISON® XL Analyzer is an automated discrete continuous loading chemiluminescent immunoassay (CLIA) usd with FA cleared chemiluminecent mmunoassays that re marketed by DiaSorin r the LIAISN XLAnalyze. Thenalyzn hi pryayhias bee pvuy for use with FDA cleared assays.

ThLIAConrolAntiHAV(netve n posivisnterus assay uliycno monitor the performance of the LIAISON® Anti-HAV assay.

Th pom harisic  LIAl cotols hav ot bee establihe r he assa stnt platforms different from LIAISON®, LIAISON® XL and LIAISON® XL with LIAISON® XL Workcell Upgrade Kit.

# This section applies only to requirements of the Paperwork Reduction Act of 1995.

O NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELO

The burden timeorhs collectioninformation sestated toavergeours per esponse, ncludi e time to review instructions, search existing data sources, gather and maintain the data needed and complee and review the collection f information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."